United Capital Management of KS Inc. Acquires 5,245 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

United Capital Management of KS Inc. grew its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 137,483 shares of the exchange traded fund’s stock after acquiring an additional 5,245 shares during the period. SPDR S&P Biotech ETF accounts for 2.8% of United Capital Management of KS Inc.’s portfolio, making the stock its 12th largest holding. United Capital Management of KS Inc.’s holdings in SPDR S&P Biotech ETF were worth $12,746,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. ICA Group Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $27,000. Scarborough Advisors LLC bought a new stake in SPDR S&P Biotech ETF during the 4th quarter worth approximately $32,000. BOCHK Asset Management Ltd purchased a new position in SPDR S&P Biotech ETF during the fourth quarter valued at approximately $36,000. ORG Partners LLC bought a new position in shares of SPDR S&P Biotech ETF in the second quarter worth approximately $40,000. Finally, Vima LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth $45,000.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $101.26 on Friday. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52. The company’s fifty day moving average price is $97.17 and its 200-day moving average price is $93.60. The company has a market capitalization of $7.72 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.